Indian drugmaker Mankind Pharma reported a fourth-quarter profit that beat analysts' estimates on Wednesday, driven by strong ...

Mankind Pharma has announced a definitive agreement for the acquisition of a 100% stake in Bharat Serums and Vaccines (BSV) from private equity investor Advent International in a Rs136.3bn ($1.6bn ...

Mankind Pharma Limited on Wednesday announced that it has completed the transaction to acquire 100% stake in Bharat Serums and Vaccines Limited (BSV), for a purchase consideration of Rs.

July 25 (Reuters) - Indian drugmaker Mankind Pharma (MNKI.NS), opens new tab said late on Thursday it would acquire Bharat Serums and Vaccines Ltd in a deal valued at around 136.30 billion rupees ...

Mankind had a 4.4% share of the highly fragmented domestic pharma market as of end-August. Analyst Shah says moving into the top three “is not an impossible goal.” But Mankind faces challenges.

As Mankind Pharma gears up to go public, its 544-page draft IPO paper throws up an interesting name, Dabur India. One wonders why would a century-old fast-moving consumer goods (FMCG) major be ...

Mankind Pharma, one of India’s leading pharmaceutical companies, on Monday announced its entry into the topical analgesic market through its consumer business division. According to the company ...

Mankind Pharma has clinched the deal to acquire Bharat Serums and Vaccines from private equity firm Advent International for ₹13,630 crore, the company said in a release. The Delhi-based pharma ...

As I step into Rajeev Juneja’s office at Mankind Pharma’s Delhi headquarters, the wall in front of me immediately commands attention. It features a collection of iconic quotes and striking ...